Employers invited to sign-up to Charter on first-ever World Menopause & Work Day Launch 7 September 2021 at Open Day to kick off global Congress An initiative to transform global menopause policy in the workplace will be launched at a free Open Door event on 7 September 2021 to mark the 13th European Menopause and…
NEW PUBLICATION: EMAS is extremely proud to announce the EMAS 2021 Global Recommendations on Menopause in the Workplace. This will be followed by a Menopause Charter for employers and a Self-Assessment tool for employers and managers. Read more: https://emas-online.org/emas-and-menopause-in-the-workplace-2021 Menopause in the Workplace
Vulvovaginal atrophy is a chronic condition caused by estrogen deficiency which affects around 50% of postmenopausal women. EMAS has published a clinical guide on the use of both topical estrogens and non-hormonal lubricants and moisturizers so that treatment can be individualized. Read more https://www.sciencedirect.com/science/article/pii/S037851222100061X
February 11, 2020 – European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) Position statement on managing the menopause after gynecological cancer Worldwide, 1.3 million new gynecological cancer cases are diagnosed each year. Treatment can result in loss of ovarian function and, in women under the age of 45, early menopause. This position…